HepTcell Immunotherapy

· Altimmune, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HepTcell Immunotherapy, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) [Phase 2]